[ Price : $8.95]
Federal Register notice: FDA announces a 6/4 Psychopharmacologic Drugs Advisory Committee meeting to discuss a Lykos Therapeutics ...[ Price : $8.95]
CBER director Peter Marks says FDA is working to achieve 90% correct decisions on gene therapy accelerated approvals.[ Price : $8.95]
Three Winston & Strawn attorneys say that by declining to hear an appeal, the Supreme Court has affirmed that some state law claim...[ Price : $8.95]
CDER director Patrizia Cavazzoni provides an update on the reorganization of FDAs Office of Regulatory Affairs (ORA) regarding ins...[ Price : $8.95]
FDA grants Avidity Biosciences a breakthrough therapy designation for delpacibart etedesiran and its use in treating myotonic dyst...[ Price : $8.95]
FDA reminds healthcare providers and facilities about the agencys continuing safety and quality concerns with some Getinge/Maquet ...[ Price : $8.95]
FDA says it has worked with EPA and USDA to develop a biotechnology regulatory reform program as required by a presidential Execut...[ Price : $8.95]
FDA grants in part and denies in part a 14-year-old Kaiser Permanente petition on the development, implementation, and evaluation ...